Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer

Clinical trial NCT01186484 · COMPLETED

Trial details

NCT number: NCT01186484
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2010-06-01
Primary completion: 2014-10-02
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.